Showing results (151-160 of 969) with videos related to
Sort By:
Pageof 97
Statistics in Medicine|June 8, 2021
A Bayesian hierarchical monitoring design for phase II cancer clinical trials: Incorporating information on response duration into monitoring rulesJian Wang, Junsheng Ma, Chunyan Cai, et al.Leukemia & Lymphoma|March 29, 2011
The microenvironment in hairy cell leukemia: pathways and potential therapeutic targetsJan A Burger, Mariela Sivina, Farhad RavandiExpert Review of Hematology|May 4, 2022
BTK inhibitor selection for chronic lymphocytic leukemia: which drug for which patient?Sai Prasad Desikan, Sangeetha Venugopal, Alessandra FerrajoliExpert Review of Hematology|January 31, 2023
An overview of novel therapies in advanced clinical testing for acute myeloid leukemiaSangeetha Venugopal, Zhuoer Xie, Amer M ZeidanBlood Reviews|August 2, 2020
Loss of 5q in myeloid malignancies - A gain in understanding of biological and clinical consequencesSangeetha Venugopal, John Mascarenhas, David P SteensmaBreast Cancer (Dove Medical Press)|March 31, 2017
Breast cancer in patients with Li-Fraumeni syndrome - a case-series study and review of literatureAmara G Nandikolla, Sangeetha Venugopal, Jesus AnampaJournal of Hematology & Oncology|June 16, 2021
Impact of frontline treatment approach on outcomes of myeloid blast phase CMLKapil Saxena, Elias Jabbour, Ghayas Issa, et al.American Journal of Hematology|July 19, 2020
Phase I/II study of dasatinib in combination with decitabine in patients with accelerated or blast phase chronic myeloid leukemiaYasmin Abaza, Hagop Kantarjian, Yasmin Alwash, et al.American Journal of Hematology|July 23, 2020
Phase 1 study of combinatorial sorafenib, G-CSF, and plerixafor treatment in relapsed/refractory, FLT3-ITD-mutated acute myelogenous leukemia patientsGautam Borthakur, Zhihong Zeng, Jorge E Cortes, et al.Cancer|June 1, 2019
Unrecognized fluid overload during induction therapy increases morbidity in patients with acute promyelocytic leukemiaKamal Chamoun, Hagop M Kantarjian, Xuemei Wang, et al.Pageof 97